ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesD81.81

D81.81

Billable

Biotin-dependent carboxylase deficiency

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 D81.81 is a billable code used to indicate a diagnosis of biotin-dependent carboxylase deficiency.

Key Diagnostic Point:

Biotin-dependent carboxylase deficiency is a rare inherited metabolic disorder characterized by a deficiency in one or more of the biotin-dependent carboxylase enzymes. These enzymes play a crucial role in the metabolism of carbohydrates, fats, and proteins. The deficiency leads to a range of clinical manifestations, including developmental delays, neurological symptoms, and metabolic disturbances. Patients may present with symptoms such as hypotonia, seizures, skin rashes, and alopecia. The condition is often diagnosed in infancy or early childhood, and it can be associated with elevated levels of organic acids in urine, particularly 3-hydroxyisovaleric acid and 3-hydroxypropionic acid. Early diagnosis and treatment with biotin supplementation can significantly improve outcomes and prevent complications. However, if left untreated, the condition can lead to severe neurological impairment and other serious health issues. Management typically involves dietary modifications and regular monitoring of metabolic parameters to ensure optimal health and development.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Limited awareness of the condition among healthcare providers
  • Variability in clinical presentation and symptoms
  • Need for biochemical testing to confirm diagnosis
  • Potential for misdiagnosis with other metabolic disorders

Audit Risk Factors

  • Inadequate documentation of clinical symptoms
  • Failure to document biochemical test results
  • Lack of clarity on dietary management
  • Misalignment between diagnosis and treatment provided

Specialty Focus

Medical Specialties

Pediatrics

Documentation Requirements

Detailed history of developmental milestones, clinical symptoms, and metabolic testing results.

Common Clinical Scenarios

Infants presenting with developmental delays, seizures, or skin rashes.

Billing Considerations

Ensure thorough documentation of dietary interventions and response to biotin supplementation.

Genetics

Documentation Requirements

Family history, genetic testing results, and metabolic evaluations.

Common Clinical Scenarios

Patients with a family history of metabolic disorders or unexplained neurological symptoms.

Billing Considerations

Document genetic counseling provided and any recommendations for family screening.

Coding Guidelines

Inclusion Criteria

Use D81.81 When
  • Follow ICD
  • CM guidelines for coding metabolic disorders
  • Ensure that the diagnosis is supported by clinical findings and laboratory results
  • Document any related conditions or complications that may arise from the deficiency

Exclusion Criteria

Do NOT use D81.81 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

83001CPT Code

Biotin level test

Clinical Scenario

Used to confirm biotin deficiency in patients presenting with symptoms.

Documentation Requirements

Document the clinical rationale for testing and results.

Specialty Considerations

Ensure that the testing aligns with the clinical presentation and is supported by metabolic evaluations.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of metabolic disorders, including biotin-dependent carboxylase deficiency. This specificity aids in better tracking of the condition and improves the accuracy of reimbursement.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of metabolic disorders, including biotin-dependent carboxylase deficiency. This specificity aids in better tracking of the condition and improves the accuracy of reimbursement.

Reimbursement & Billing Impact

reimbursement.

Resources

Clinical References

  • •
    National Organization for Rare Disorders (NORD)

Coding & Billing References

  • •
    National Organization for Rare Disorders (NORD)

Frequently Asked Questions

What are the common symptoms of biotin-dependent carboxylase deficiency?

Common symptoms include developmental delays, neurological issues such as seizures, skin rashes, and alopecia. These symptoms can vary widely among patients.